Three-Year Patency Results following Endovascular Transvenous Femoropopliteal Bypass

Simple item page
dc.contributor.authorRumba, Roberts
dc.contributor.authorKrievins, Dainis
dc.contributor.authorSavlovskis, Janis
dc.contributor.authorEzite, Natalija
dc.contributor.authorLacis, Aigars
dc.contributor.authorPetrosina, Eva
dc.contributor.authorMouttet, Ludovic
dc.contributor.authorGardovskis, Janis
dc.contributor.authorZarins, Christopher K.
dc.contributor.institutionRīga Stradiņš University
dc.contributor.institutionStatistics Unit
dc.date.accessioned2023-12-14T16:10:02Z
dc.date.available2023-12-14T16:10:02Z
dc.date.issued2023-02-25
dc.descriptionPublisher Copyright: © 2023 by the authors.
dc.description.abstractBackground and Objectives: Peripheral artery disease is one of the most common vascular pathologies. There is an ongoing debate among specialists on whether open or endovascular revascularization is preferred in cases of complex superficial femoral artery (SFA) lesions. The purpose of this study was to assess patency results of a relatively new transvenous endovascular bypass device. This could add to existing evidence and aid in comparison between open and endovascular bypass. Materials and Methods: Patients with complex TASC-C and D SFA lesions who had indications for revascularization were identified. Prospective analysis of stent graft patency from 54 transvenous femoropopliteal bypass procedures was performed. Patency was assessed by Duplex ultrasound every six months. Kaplan–Meier analysis was performed to assess primary, primary-assisted, and secondary patency of transvenous bypass. Results: Following endovascular transvenous femoropopliteal bypass, 3-year graft primary, primary-assisted, and secondary patency was 43.8%, 66.3%, and 73.9%, respectively. Conclusions: Transvenous endovascular femoropopliteal bypass is a viable option for selected patients who lack adequate saphenous vein or have comorbidities that increase the risk of open femoropopliteal bypass. Strict post-operative follow-up is necessary to improve patency rates.en
dc.description.statusPeer reviewed
dc.format.extent10
dc.format.extent1604281
dc.identifier.citationRumba, R, Krievins, D, Savlovskis, J, Ezite, N, Lacis, A, Petrosina, E, Mouttet, L, Gardovskis, J & Zarins, C K 2023, 'Three-Year Patency Results following Endovascular Transvenous Femoropopliteal Bypass', Medicina (Lithuania), vol. 59, no. 3, 462. https://doi.org/10.3390/medicina59030462
dc.identifier.doi10.3390/medicina59030462
dc.identifier.issn1010-660X
dc.identifier.urihttps://dspace.rsu.lv/jspui/handle/123456789/15057
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85151109477&partnerID=8YFLogxK
dc.language.isoeng
dc.relation.ispartofMedicina (Lithuania)
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectendovascular femoropopliteal bypass
dc.subjectpatency data
dc.subjecttransvenous femoropopliteal bypass
dc.subject3.2 Clinical medicine
dc.subject1.1. Scientific article indexed in Web of Science and/or Scopus database
dc.subjectGeneral Medicine
dc.titleThree-Year Patency Results following Endovascular Transvenous Femoropopliteal Bypassen
dc.type/dk/atira/pure/researchoutput/researchoutputtypes/contributiontojournal/article

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Three-Year_Patency_Results_following_Endovascular.pdf
Size:
1.53 MB
Format:
Adobe Portable Document Format
Download

Collections

Research outputs from Pure / Zinātniskās darbības rezultāti no ZDIS Pure